796 related articles for article (PubMed ID: 8214760)
21. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes.
Rifkind AB; Lee C; Chang TK; Waxman DJ
Arch Biochem Biophys; 1995 Jul; 320(2):380-9. PubMed ID: 7625847
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of the chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane by rat and human liver microsomes: the role of cytochrome P450 2E1.
Urban G; Speerschneider P; Dekant W
Chem Res Toxicol; 1994; 7(2):170-6. PubMed ID: 8199305
[TBL] [Abstract][Full Text] [Related]
23. Benzene metabolism by human liver microsomes in relation to cytochrome P450 2E1 activity.
Seaton MJ; Schlosser PM; Bond JA; Medinsky MA
Carcinogenesis; 1994 Sep; 15(9):1799-806. PubMed ID: 7923572
[TBL] [Abstract][Full Text] [Related]
24. Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1.
Kharasch ED; Thummel KE; Mhyre J; Lillibridge JH
Clin Pharmacol Ther; 1993 Jun; 53(6):643-50. PubMed ID: 8513656
[TBL] [Abstract][Full Text] [Related]
25. Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers.
Hong JY; Wang YY; Mohr SN; Bondoc FY; Deng C
Res Rep Health Eff Inst; 2001 May; (102):7-27; discussion 95-109. PubMed ID: 11504148
[TBL] [Abstract][Full Text] [Related]
26. 7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes.
Yamazaki H; Inoue K; Mimura M; Oda Y; Guengerich FP; Shimada T
Biochem Pharmacol; 1996 Feb; 51(3):313-9. PubMed ID: 8573198
[TBL] [Abstract][Full Text] [Related]
27. Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone.
Carriere V; Goasduff T; Ratanasavanh D; Morel F; Gautier JC; Guillouzo A; Beaune P; Berthou F
Chem Res Toxicol; 1993; 6(6):852-7. PubMed ID: 7509644
[TBL] [Abstract][Full Text] [Related]
28. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J
Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706
[TBL] [Abstract][Full Text] [Related]
29. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
Teiber JF; Hollenberg PF
Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
[TBL] [Abstract][Full Text] [Related]
30. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
[TBL] [Abstract][Full Text] [Related]
31. Metabolism in vitro of enflurane, isoflurane, and methoxyflurane.
Greenstein LR; Hitt BA; Mazze RI
Anesthesiology; 1975 Apr; 42(4):420-4. PubMed ID: 1119709
[TBL] [Abstract][Full Text] [Related]
32. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
33. Renal effects and metabolism of sevoflurane in Fisher 3444 rats: an in-vivo and in-vitro comparison with methoxyflurane.
Cook TL; Beppu WJ; Hitt BA; Kosek JC; Mazze RI
Anesthesiology; 1975 Jul; 43(1):70-7. PubMed ID: 1147310
[TBL] [Abstract][Full Text] [Related]
34. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1.
Duescher RJ; Elfarra AA
Arch Biochem Biophys; 1994 Jun; 311(2):342-9. PubMed ID: 8203896
[TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.
Yamazaki H; Inui Y; Yun CH; Guengerich FP; Shimada T
Carcinogenesis; 1992 Oct; 13(10):1789-94. PubMed ID: 1423839
[TBL] [Abstract][Full Text] [Related]
36. Uptake and biotransformation of sevoflurane in humans: a comparative study of sevoflurane with halothane, enflurane, and isoflurane.
Shiraishi Y; Ikeda K
J Clin Anesth; 1990; 2(6):381-6. PubMed ID: 2271202
[TBL] [Abstract][Full Text] [Related]
37. Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1.
Zerilli A; Ratanasavanh D; Lucas D; Goasduff T; Dréano Y; Menard C; Picart D; Berthou F
Chem Res Toxicol; 1997 Oct; 10(10):1205-12. PubMed ID: 9348445
[TBL] [Abstract][Full Text] [Related]
38. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
Ekström G; Gunnarsson UB
Drug Metab Dispos; 1996 Sep; 24(9):955-61. PubMed ID: 8886604
[TBL] [Abstract][Full Text] [Related]
39. Liver function and anesthetic metabolism in rats with chronic renal impairment.
Rice SA; Sievenpiper TS; Mazze RI
Anesthesiology; 1984 May; 60(5):418-21. PubMed ID: 6711854
[TBL] [Abstract][Full Text] [Related]
40. New insights into the mechanism of methoxyflurane nephrotoxicity and implications for anesthetic development (part 1): Identification of the nephrotoxic metabolic pathway.
Kharasch ED; Schroeder JL; Liggitt HD; Park SB; Whittington D; Sheffels P
Anesthesiology; 2006 Oct; 105(4):726-36. PubMed ID: 17006072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
